Interestingly, basic fibroblast growth factor (bFGF) was confirmed to reverse the effect of diabetes on AD-MSCs by improving morphology, increasing proliferative activity, and reducing cellular senescence and apoptosis with decreased oxidative stress [92]. The gene discussed is FGF2; the disease is diabetes mellitus.